Predicted to enable nucleic acid binding activity. Predicted to act upstream of or within hematopoietic progenitor cell differentiation. Orthologous to human GPATCH4 (G-patch domain containing 4 (gene/pseudogene)). [provided by Alliance of Genome Resources, Apr 2022]